Author Correction: Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer. - Chmielecki J; Gray JE; Cheng Y; Ohe Y; Imamura F; Cho BC; Lin MC; Majem M; Shah R; Rukazenkov Y; Todd A; Markovets A; et al. (Nature communications, 2023)